{
    "2019-03-05": [
        [
            {
                "time": "",
                "original_text": "【增减持】药明康德(02359.HK)遭摩根大通减持21.61万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
                "features": {
                    "keywords": [
                        "银行股",
                        "历史梳理",
                        "大行情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-04",
                "original_text": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
                "features": {
                    "keywords": [
                        "科创板",
                        "医药创新",
                        "上市路径",
                        "创新引领未来"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "昭衍新药股价创新高 创新板带来创新型医药资产重估机会？",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "股价创新高",
                        "创新板",
                        "医药资产重估"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}